eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 4 : 317-323 doi: ijmmas.2005.317.323
Research Article
Paracrine Transformation to Autocrine Autonomy in Tumor Cell Proliferation and Spread. Is the Neoplastic Blood Supply a Functional Determinant of Clonality In Inducing Biologic Tumor Progressiveness?
Published
June 30, 2005
Abstract

A theory of selectivity in terms of clonal progression of neoplasms might directly implicate a primary susceptibility of blood supply systems in transformation of paracrine responsiveness to autocrine autonomy. Subsequent neoplastic evolution might constitute forms of establishment of aberrant vascularity in inducing a clonality of tumor cell subpopulations that are integrally a single system of progression through transformation. In various ways, the active processes of tumor cell proliferation and spread through infiltration and metastases would paradoxically constitute systems of operative autonomy within a context of evolving influence. Indeed, clonality of neoplastic progression might involve a transformation that integrally evolves simply as patterns of aberrant blood supply both in initial establishment and in subsequent evolution towards higher tumor grades. In simple terms, perhaps, one might speak of different modes of evolving transformation of tumor cells as clonally derived cells centered on aberrant blood supply that is inherently a point of reference in terms even of basic malignant transformation as a carcinogenic event. Beyond even considerations of strict initial malignant transformation, however, aberrant blood supply systems would constitute a persistent source of transformation in establishing neoplastic progression in terms largely of biologic attributes of clonality towards transformation of paracrine responsiveness to autocrine autonomy.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Predictors of Acute Coronary Syndrome Outcomes: A Multicenter Evaluation of Clinical, Biochemical, and Demographic Risk Factors
11-15
Smart Hospitals and Healthcare Automation: Transforming Healthcare Delivery Through Artificial Intelligence, Internet of Medical Things, and Intelligent Automation
16-20
PCI Outcomes in Patients With Chronic Total Occlusion
14-17
Impact of Dual Antiplatelet Therapy Duration on Post-PCI Outcomes
11-14
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.